50% Commission Offering for Initial Distributors. Amnio-Maxx™ will be used to treat various conditions in orthopedics and sports medicine.
US Surgeon General, VADM Jerome M. Adams, MD, MPH, will address the APS' 3rd Annual Conference on Analgesic Trials (APS-CAT) - March 4, 2018
OssDsign AB, a Swedish designer, manufacturer and distributor of next generation implants for cranial and facial reconstruction, today announced that it has established a US subsidiary and made initial key recruitments.
Network Now Has Members on Six Continents
Study will use innovative technology to focus on neurodegenerative diseases
Cedrus' Chairman, Mr. Rani Jarkas said, "We have seen growing interest from Chinese enterprises and investors to acquire life sciences technologies and products overseas, and the increased desire of Australian life science companies to build a presence in China, the second-largest biopharma market in the world."
Specialty therapy management company will host a webinar to explore current trends and provide actionable insights for pharmacy leaders